Zizhang Sheng

13.4k total citations · 4 hit papers
61 papers, 3.8k citations indexed

About

Zizhang Sheng is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Zizhang Sheng has authored 61 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 20 papers in Immunology and 19 papers in Infectious Diseases. Recurrent topics in Zizhang Sheng's work include Influenza Virus Research Studies (24 papers), Respiratory viral infections research (18 papers) and SARS-CoV-2 and COVID-19 Research (15 papers). Zizhang Sheng is often cited by papers focused on Influenza Virus Research Studies (24 papers), Respiratory viral infections research (18 papers) and SARS-CoV-2 and COVID-19 Research (15 papers). Zizhang Sheng collaborates with scholars based in United States, China and Hong Kong. Zizhang Sheng's co-authors include Yicheng Guo, David D. Ho, Feng Li, Sho Iketani, Lihong Liu, Jian Yu, Ben M. Hause, Maple Wang, Dan Wang and Emily A. Collin and has published in prestigious journals such as Nature, Cell and Immunity.

In The Last Decade

Zizhang Sheng

58 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

2022 495 citations Qian Wang, Sho Iketani et al. Cell profile →
Antibody evasion properties of SARS-CoV-2 Omicron sublineages

2022 478 citations Sho Iketani, Lihong Liu et al. Nature profile →
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

2022 433 citations Qian Wang, Yicheng Guo et al. Nature profile →
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

2022 260 citations Sho Iketani, Hiroshi Mohri et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zizhang Sheng United States	28	2.2k	1.1k	1.0k	725	491	61	3.8k
Ralf Altmeyer France	31	2.0k 0.9×	778 0.7×	934 0.9×	749 1.0×	215 0.4×	58	3.8k
Xuguang Li Canada	31	1.8k 0.8×	1.0k 0.9×	1.2k 1.2×	687 0.9×	344 0.7×	125	3.6k
Akikazu Murakami Japan	16	1.4k 0.7×	945 0.9×	700 0.7×	661 0.9×	495 1.0×	46	2.9k
Sheng Cui China	34	1.4k 0.6×	502 0.5×	2.4k 2.3×	1.6k 2.2×	285 0.6×	82	4.4k
Guangyu Zhao China	37	2.4k 1.1×	1.1k 1.0×	955 0.9×	1.0k 1.4×	313 0.6×	100	3.9k
Darwyn Kobasa Canada	34	2.2k 1.0×	3.1k 2.9×	874 0.8×	1.4k 1.9×	126 0.3×	114	5.1k
Thomas P. Peacock United Kingdom	24	2.0k 0.9×	953 0.9×	686 0.7×	415 0.6×	114 0.2×	47	2.9k
Weijin Huang China	30	3.4k 1.6×	737 0.7×	1.1k 1.0×	425 0.6×	214 0.4×	186	4.8k
José L. Nieva Spain	36	896 0.4×	683 0.6×	2.5k 2.4×	657 0.9×	413 0.8×	118	4.1k
Megan L. Shaw United States	26	1.7k 0.8×	2.7k 2.5×	1.3k 1.2×	1.3k 1.8×	93 0.2×	56	4.5k

Countries citing papers authored by Zizhang Sheng

Since Specialization

Citations

This map shows the geographic impact of Zizhang Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zizhang Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zizhang Sheng more than expected).

Fields of papers citing papers by Zizhang Sheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zizhang Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zizhang Sheng. The network helps show where Zizhang Sheng may publish in the future.

Co-authorship network of co-authors of Zizhang Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Zizhang Sheng. A scholar is included among the top collaborators of Zizhang Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zizhang Sheng. Zizhang Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yipei, Guanghong Liu, Lianjie Zhang, et al.. (2025). Green Modular Convergent Synthesis of Non‐Fullerene Acceptor for SWIR Organic Photodetectors. Macromolecular Rapid Communications. 47(2). e00728–e00728.

McHugh, Kirsty, Rebecca Li, Yicheng Guo, et al.. (2024). Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates. npj Vaccines. 9(1). 198–198. 3 indexed citations

Guo, Yicheng, Eric Waltari, Hong Lü, Zizhang Sheng, & Xueling Wu. (2024). Novel rhesus macaque immunoglobulin germline genes identified by three sequencing approaches. Frontiers in Immunology. 15. 1506348–1506348.

Nair, Manoj S., Ruy M. Ribeiro, Maple Wang, et al.. (2023). Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost. iScience. 26(4). 106345–106345. 3 indexed citations

Wang, Qian, Zhiteng Li, Yicheng Guo, et al.. (2023). Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2. iScience. 26(11). 108254–108254. 13 indexed citations

Liu, Lihong, Ryan G. Casner, Yicheng Guo, et al.. (2023). Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking. Immunity. 56(10). 2442–2455.e8. 12 indexed citations

Iketani, Sho, Lihong Liu, Yicheng Guo, et al.. (2022). Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 604(7906). 553–556. 478 indexed citations breakdown →

Iketani, Sho, Hiroshi Mohri, Bruce Culbertson, et al.. (2022). Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir. Nature. 613(7944). 558–564. 260 indexed citations breakdown →

Wang, Qian, Yicheng Guo, Sho Iketani, et al.. (2022). Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 608(7923). 603–608. 433 indexed citations breakdown →

10.

Wang, Qian, Sho Iketani, Zhiteng Li, et al.. (2022). Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 186(2). 279–286.e8. 495 indexed citations breakdown →

11.

Cerutti, Gabriele, Yicheng Guo, Pengfei Wang, et al.. (2021). Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain. Cell Reports. 37(5). 109928–109928. 42 indexed citations

12.

Cerutti, Gabriele, Micah Rapp, Yicheng Guo, et al.. (2021). Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure. 29(7). 655–663.e4. 40 indexed citations

13.

Annavajhala, Medini K., Hiroshi Mohri, Pengfei Wang, et al.. (2021). Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature. 597(7878). 703–708. 80 indexed citations

14.

Chen, Xuejun, Tongqing Zhou, Stephen D. Schmidt, et al.. (2021). Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with >50% breadth. Immunity. 54(2). 324–339.e8. 23 indexed citations

15.

Guo, Yicheng, Kevin Chen, Peter D. Kwong, Lawrence Shapiro, & Zizhang Sheng. (2019). cAb-Rep: A Database of Curated Antibody Repertoires for Exploring Antibody Diversity and Predicting Antibody Prevalence. Frontiers in Immunology. 10. 2365–2365. 32 indexed citations

16.

Chuang, Gwo‐Yu, Jing Zhou, Priyamvada Acharya, et al.. (2018). Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition. Structure. 27(1). 196–206.e6. 43 indexed citations

17.

Sheng, Zizhang, Chaim A. Schramm, Mark Connors, et al.. (2016). Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection. PLoS Computational Biology. 12(5). e1004940–e1004940. 23 indexed citations

18.

Wu, Xueling, Zhenhai Zhang, Chaim A. Schramm, et al.. (2015). Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection. Cell. 161(3). 470–485. 150 indexed citations

19.

Chakravarty, Suvobrata, et al.. (2012). “η⁶”‐Type anion–π in biomolecular recognition. FEBS Letters. 586(23). 4180–4185. 42 indexed citations

20.

Zhao, Yuqi, Zizhang Sheng, & Jing‐Fei Huang. (2011). A systematic analysis of heart transcriptome highlights divergent cardiovascular disease pathways between animal models and humans. Molecular BioSystems. 8(2). 504–510. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact